Biopromic
BioPromic is dedicated to developing innovative diagnostic solutions and biotechnologies, including antibodies, antigens, reagents, and sample preparation technologies. They collaborate globally to co-develop low-cost diagnostic tools for infectious diseases like tuberculosis, and have received grants and nominations for their advancements in health technology.
Industries
Nr. of Employees
small (1-50)
Products
Antibodies
Research and diagnostic-grade antibodies offered for use in immunoassays and biosensors.
Antigens
Purified antigens for use as assay targets or controls in diagnostic assays.
Research reagents
General reagents for laboratory assays and diagnostic workflows.
Functionalized nanoparticles
Gold and magnetic particles and related functionalized nanoparticle reagents for use in biosensors and point-of-care assays.
Sample preparation kits and protocols
Sample processing reagents and validated workflows to prepare clinical specimens for downstream diagnostic testing.
Antibodies
Research and diagnostic-grade antibodies offered for use in immunoassays and biosensors.
Antigens
Purified antigens for use as assay targets or controls in diagnostic assays.
Research reagents
General reagents for laboratory assays and diagnostic workflows.
Functionalized nanoparticles
Gold and magnetic particles and related functionalized nanoparticle reagents for use in biosensors and point-of-care assays.
Sample preparation kits and protocols
Sample processing reagents and validated workflows to prepare clinical specimens for downstream diagnostic testing.
Services
Contract services including custom antibody/antigen reagent production, conjugation of biomolecules to particles, particle functionalization, and development of sample preparation workflows for diagnostic assays.
Contract services including custom antibody/antigen reagent production, conjugation of biomolecules to particles, particle functionalization, and development of sample preparation workflows for diagnostic assays.
Expertise Areas
- Point-of-care diagnostic development
- Immunoassay development
- Nanoparticle engineering and functionalization
- Conjugation chemistry
Key Technologies
- Plasmonic grating biosensors
- Gold nanoparticles
- Magnetic nanoparticles
- Antibody-antigen reagents
News & Updates
Biopromic, in collaboration with Asahi Kasei, received a GHIT grant to develop a low-cost, sensitive point-of-care diagnostic platform for infectious diseases.
The company received a grant from Vinnova to support its health technology innovations.
Recognition of Biopromic's innovative health solutions through nomination to the European Health Catapult.
Biopromic partners with Global Good to co-develop low-cost diagnostic tools for tuberculosis detection.
Development of biosensors for detecting tuberculosis markers in clinical samples.
Awarded GHIT grant for developing a sensitive LFA platform for infectious diseases.
Biopromic, in collaboration with Asahi Kasei, received a GHIT grant to develop a low-cost, sensitive point-of-care diagnostic platform for infectious diseases.
The company received a grant from Vinnova to support its health technology innovations.
Recognition of Biopromic's innovative health solutions through nomination to the European Health Catapult.
Biopromic partners with Global Good to co-develop low-cost diagnostic tools for tuberculosis detection.
Development of biosensors for detecting tuberculosis markers in clinical samples.
Awarded GHIT grant for developing a sensitive LFA platform for infectious diseases.